Literature DB >> 8689931

Interferon-associated left ventricular dysfunction in a liver transplant recipient.

R Mateo1, S Jethmalani, D C Angus, J Gorcsan, B Uretsky, J Fung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8689931     DOI： 10.1007/bf02088579

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  19 in total

1.  QT prolongation and Torsades de Pointes after administration of FK506.

Authors:  M C Johnson; S So; J W Marsh; A M Murphy
Journal:  Transplantation       Date:  1992-04       Impact factor: 4.939

2.  Cardiopulmonary toxicity after liposomal amphotericin B infusion.

Authors:  S J Levine; T J Walsh; A Martinez; P Q Eichacker; G Lopez-Berestein; C Natanson
Journal:  Ann Intern Med       Date:  1991-04-15       Impact factor: 25.391

3.  Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma.

Authors:  L R Deyton; R E Walker; J A Kovacs; B Herpin; M Parker; H Masur; A S Fauci; H C Lane
Journal:  N Engl J Med       Date:  1989-11-02       Impact factor: 91.245

Review 4.  Adverse effects associated with the use of FK 506.

Authors:  J J Fung; M Alessiani; K Abu-Elmagd; S Todo; R Shapiro; A Tzakis; D Van Thiel; J Armitage; A Jain; J McCauley
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 5.  Side effects of alpha interferon.

Authors:  P F Renault; J H Hoofnagle
Journal:  Semin Liver Dis       Date:  1989-11       Impact factor: 6.115

6.  Recombinant alpha 2 interferon-related cardiomyopathy.

Authors:  M C Cohen; M S Huberman; R W Nesto
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

7.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

Authors:  A M Di Bisceglie; P Martin; C Kassianides; M Lisker-Melman; L Murray; J Waggoner; Z Goodman; S M Banks; J H Hoofnagle
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

8.  Serum kynurenine and neopterin concentrations in patients with cardiomyopathy.

Authors:  V Rudzite; J I Skards; D Fuchs; G Reibnegger; H Wachter
Journal:  Immunol Lett       Date:  1992-04       Impact factor: 3.685

9.  Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.

Authors:  F M Foss; D C Ihde; D L Breneman; R M Phelps; A B Fischmann; G P Schechter; I Linnoila; J C Breneman; J D Cotelingam; B C Ghosh
Journal:  J Clin Oncol       Date:  1992-12       Impact factor: 44.544

10.  Left-sided heart failure presenting as hepatitis.

Authors:  J A Cohen; M M Kaplan
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682
View more
  1 in total

Review 1.  Treatment of hepatitis C virus infection and associated vascular complications: a literature review.

Authors:  Reza Karbasi-Afshar
Journal:  Iran J Med Sci       Date:  2014-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.